Columbia Financial, Inc. filings document material events for the holding company of Columbia Bank, including furnished earnings releases, Regulation FD presentation materials, governance updates and capital-structure disclosures. Recent 8-K filings record operating and financial results, executive appointments, officer-designation matters and board succession disclosures involving the company and its wholly owned bank subsidiary.
The filing record also covers shareholder voting matters, material agreements and corporate-governance items that relate to Columbia Financial’s public-company reporting obligations. These disclosures connect the company’s banking operations with formal records on financial performance, management responsibilities, board composition and securities-related actions.
Columbia Financial, Inc. executive John Klimowich, SEVP & Chief Risk Officer, reported a compensation-related acquisition of 39.7804 shares of Common Stock at $17.2100 per share on March 20, 2026. The shares are phantom stock credited under the Columbia Bank Stock Based Deferral Plan and will be settled in stock upon distribution.
Columbia Financial, Inc. President & CEO Thomas J. Kemly reported a compensation-related stock award rather than an open-market trade. On March 20, 2026, a trustee for the Columbia Bank Stock Based Deferral Plan acquired 107.9425 phantom stock units at $17.21 per unit on a non-discretionary basis for his account. This increased his indirect beneficial interest in that plan to 68,934.7367 stock unit interests, which will be settled in shares upon distribution. The filing also lists multiple outstanding stock option grants under the 2019 Equity Incentive Plan, with exercise prices between $15.60 and $18.28 and expirations from 2029 through 2036, some fully vested and others vesting in annual installments.
Columbia Financial EVP & CIO Prabhu Manesh Balachandran reported a compensation-related increase in indirect holdings. On March 13, 2026, a grant of 476.7191 shares of Columbia Financial, Inc. common stock at $17.48 per share was credited under a stock-based deferral plan, raising that plan balance to 1,022.3166 shares. He also reports outstanding stock options, including 12,985 underlying shares at an exercise price of $20.54, plus additional option grants and phantom stock units detailed in the filing. There were no open-market purchases or sales.
Columbia Financial, Inc. executive John Klimowich, SEVP & Chief Risk Officer, reported an indirect acquisition of 589.1476 shares of Common Stock-equivalent phantom stock at $17.4800 per unit on March 13, 2026. The units were credited under a Columbia Bank stock-based deferral plan and are held in a rabbi trust on a non-discretionary basis by the plan trustee.
After this award, his related deferral-plan balance stands at 8926.8984 stock unit interests, which will be settled in shares upon distribution. Separate from this, he holds direct stock options covering 188235, 12030, 8850, 20310 and 20227 shares of Common Stock at exercise prices between $15.6000 and $18.2800, with expirations from 2029 through 2036.
Columbia Financial, Inc. President & CEO Thomas J. Kemly acquired 1,800.2632 shares of Common Stock on March 13, 2026 at $17.48 per share through a stock-based deferral plan. These are phantom stock units held indirectly in a rabbi trust and will be settled in shares upon distribution to him.
Following this transaction, his indirect holdings in the stock-based deferral plan total 68,826.7942 shares. The filing also lists multiple outstanding stock option grants on Common Stock with exercise prices between $15.60 and $18.28 and expiration dates from 2029 through 2036, showing significant remaining equity-based compensation.
Columbia Financial, Inc. director Michael Massood Jr. reported a compensation-related stock award of common stock, classified as an acquisition, that was granted under the company’s 2019 Equity Incentive Plan and is scheduled to vest in one year on March 12, 2027.
After this grant, he holds common stock indirectly through a stock award vehicle, as well as directly and through retirement accounts, including 43,006 shares held directly, 21,384 shares in an IRA, and 35,483 shares in a Roth IRA. He also holds fully vested stock options exercisable for 83,294 shares of common stock at an exercise price of $15.60 per share, expiring on July 23, 2029.
Kuiken James Michael reported acquisition or exercise transactions in this Form 4 filing.
Columbia Financial, Inc. director James Michael Kuiken received a stock award of Common Stock as compensation under the company’s 2019 Equity Incentive Plan. The award will vest on March 12, 2027. After this grant, he indirectly holds 2,952 shares and directly holds 16,071 shares of Columbia Financial common stock.
Columbia Financial, Inc. director Lucy Sorrentini reported a compensation-related stock award of common stock, classified as an acquisition under a grant or award, pursuant to the company’s 2019 Equity Incentive Plan. These stock awards vest in one year on March 12, 2027.
Following these updates, she indirectly holds 2,952 shares of common stock from stock awards, directly holds 14,871 shares, and indirectly holds an additional 7,680.3636 shares through a stock-based deferral plan.
VAN OSTENBRIDGE PAUL reported acquisition or exercise transactions in this Form 4 filing.
Columbia Financial, Inc. director Paul Van Ostenbridge reported an equity compensation grant of common stock under the company’s 2019 Equity Incentive Plan. The stock awards vest in one year on March 12, 2027. Following this grant, he indirectly holds 2,952 shares as stock awards and 2,350 shares through an IRA, and directly holds 20,396 common shares, including shares that previously vested from stock awards.
Torres Daria Stacy-Walls reported acquisition or exercise transactions in this Form 4 filing.
Columbia Financial, Inc. director Daria Stacy-Walls reported receiving a stock award of Common Stock under the company’s 2019 Equity Incentive Plan. The award is scheduled to vest in one year on March 12, 2027. Following this grant, she holds 2,952 shares indirectly as a stock award, 11,255 shares directly, and 28,323.9273 shares indirectly through a stock-based deferral plan.